Q5117 Medicaid reimbursement rate by state (2026)
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg. Medicaid pays a median of $60.52 for Q5117 across 37 states, from $34.69 in New Mexico to $95.20 in Indiana.
- States publishing
- 37
- National median
- $60.52units vary by state
- Lowest
- $34.69New Mexico
- Highest
- $95.20Indiana
What does Medicaid pay for Q5117?
37 state Medicaid programs publish a fee-for-service rate for Q5117. The national median is $60.52 (units differ between states). Indiana pays the most, $95.20 per unit, and New Mexico the least, $34.69, a 2.7x spread.
Q5117 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 37 states with every variant, modifier and effective date.
How to read this table
- Order. States are listed from the highest published rate to the lowest. No single unit is shared by 8 or more states for Q5117, so the order is by published amount and is not a like-for-like rank.
- Medicaid rate. The most the state's fee-for-service program pays for one unit, as published. 10 of the 37 states list more than one rate for Q5117, by modifier, provider type or setting; the table shows the one that matches the provider level and setting used across states, without add-ons.
- Unit. Of the 37 states, 1 publish Q5117 per unit and 1 per 10 mg, and 35 schedules print no unit at all (a flat amount per service).
- Per hour. Q5117 is not billed in time units in these states, so no hourly figure is shown.
- Managed-care plans. The rule the state sets for its plans on this rate. What each rule means is explained below.
- % of Medicare. No Medicare physician fee schedule amount is on file for Q5117, so there is no percentage.
- Source and date. Each Source link opens the state's own document; “since” is the date the rate took effect.
Why Q5117 rates differ between states
Published rates for Q5117 run from $34.69 in New Mexico to $95.20 in Indiana. The two publish it in different units (unit versus no unit printed), so part of that gap is the unit rather than the price. Half the states pay more than the median of $60.52 and half pay less. The usual reasons for a spread like this in pharmacy rates:
- Drugs given in a practice or clinic are commonly priced from a benchmark such as average sales price or wholesale acquisition cost, which moves every quarter.
- For children, many vaccines are supplied through the federal Vaccines for Children program, so the Medicaid payment can be for administration only.
- States differ in whether they pay a fixed fee, a percentage of a benchmark or invoice cost.
Timing matters too. 32 states set the current rate for Q5117 in 2026 or later, while 1 state still pay a rate that took effect in 2022 or earlier. A state that has not updated its rate in years will drift down the ranking as others raise theirs.
What managed-care plans pay for Q5117
What a plan pays for Q5117 is negotiated privately, but the state decides how much room there is to negotiate. Here is how the rules break down across the 37 states.
In 7 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 17 states, plans negotiate and the published rate is a benchmark or out-of-network default. The rule for the remaining 13 states is not classified yet.
- Plans negotiate; the published rate applies out of network (17 states). In-network rates can be above or below the published rate. The published rate is the benchmark both sides know, and the fallback if no contract is signed.
- Plans must pay at least the published rate (6 states). The published rate is your floor. Negotiate up from it, and if a plan pays less, the contract provision is the basis for a payment dispute.
- The state sets the plan rate (1 state). There is little to negotiate on price. Contracting is about network participation, authorization and billing terms.
Plan-negotiated rates are never estimated here. To see the rule and its citation for a particular state, open that state's managed-care page, for example Indiana managed care.
Units and billing for Q5117
Q5117 is a HCPCS Level II temporary code in the pharmacy line, billed mostly by practices and clinics that administer vaccines and drugs. Q codes are temporary codes for drugs, biologicals, supplies and services. The unit depends on the code and is often a dose or an item.
Many states require the National Drug Code (NDC) on the claim alongside the billing code. Drug codes are billed in units of the dose stated in the code, so a larger dose bills more units.
Before billing, confirm the rate, unit and any modifier with the state's current schedule or the plan: the amounts here are as published, not a guarantee of payment.
Frequently asked questions
What does Medicaid pay for Q5117?
It depends on the state. Of the 37 states with a published fee-for-service rate, the median is $60.52. Indiana pays the most ($95.20 per unit) and New Mexico the least ($34.69).
Which state pays the highest Medicaid rate for Q5117?
Indiana, at $95.20 per unit, effective 2021-10-01.
Which state pays the lowest Medicaid rate for Q5117?
New Mexico, at $34.69, effective 2025-01-01. It publishes the code in a different unit from Indiana, so compare per unit with care.
What unit is Q5117 billed in?
Of the 37 states, 1 publish Q5117 per unit and 1 per 10 mg, and 35 schedules print no unit at all (a flat amount per service).
Do managed-care plans pay the same rate for Q5117?
Not necessarily. In 7 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 17 states, plans negotiate and the published rate is a benchmark or out-of-network default. The rule for the remaining 13 states is not classified yet. Each rule is cited to the plan contract, statute or notice in the workspace.